The antimicrobial activity of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa was compared. Dibekacin was found to be the most active against the tested organisms, whereas the other aminoglycoside antibiotics fell in the following order of diminishing antibacterial potency: amikacin, sisomicin, gentamicin, kanendomycin, and kanamycin. Seven strains showed high-level resistance to gentamicin (miniimal inhibitory concentration, 400 ,ug/ml), and two ofthem were also resistant to amikacin and sisomicin (minimal inhibitory concentration, 75 ,ug/ml). The miniimal inhibitory concentration of dibekacin for these seven strains was 0.625 Ag/ml. This study was carried out to compare the in vitro antibacterial activity of six aminoglycoside antibiotics, kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin, against 200 strains of Pseudomonas aeruginosa of an overnight culture in nutrient broth, containing approximately 105 colony-forming units.
miniimal inhibitory concentration of dibekacin for these seven strains was 0.625 Ag/ml. (MIC, 400 , ug/ml) , and two of the seven were also resistant to amikacin and sisomicin (MIC, 75 ug/ml). The MIC of dibekacin for these seven strains was 0.625 ,ug/ml.
At an MIC higher than 5 ,ug/ml, we found 55, 52, 18, 3, and 11% of the 200 strains tested resistant to kanamycin, kanendomycin, gentamicin, amikacin, and sisomicin, respectively. High-level resistance was defined as an MIC above 75 ,Ag/ml, and on this basis 31, 22, 4, 1, and 1% of the strains were highly resistant to kanamycin, kanendomycin, gentamicin, amikacin and sisomicin, respectively. P. aeruginosa strains resistant to high concentrations of amikacin and sisomicin were isolated for the first time in Greece, and this is important because sisomicin has not been introduced yet in Greece, and amikacin has been introduced only recently.
In conclusion, susceptibility tests of 200 strains of P. aeruginosa, all clinical isolates, showed that dibekacin (3,'4'-dideoxykanamycin B), which was derived from kanamycin B by chemical transformation (2), has potent antimicrobial activity that is also exerted against P. aeruginosa strains that are resistant to high concentrations of gentamicin, amikacin, and sisomicin. LITERATURE 
